Rewiring the Parkinsonian brain

Fricker-Gates, Rosemary A.; Dunnett, Stephen B.
February 2002
Nature Medicine;Feb2002, Vol. 8 Issue 2, p105
Academic Journal
Focuses on the clinical application of embryonic stem cells in Parkinson disease (PD). Characteristics of PD; Suggestions made on the role of stem cells as an alternative source of dopamine cells for transplantation in PD patients.


Related Articles

  • Therapeutic cloning treats Parkinson's mice.  // New Scientist;3/29/2008, Vol. 197 Issue 2649, p6 

    The article reports that an international team led by Lorenz Studer of the Sloan-Kettering Institute of New York has cured mice with a Parkinson's-like disease, using neurons cloned from their own skin cells. The mice were given a drug to kill neurons that make the neurotransmitter dopamine. The...

  • Therapeutic Potentials of Human Embryonic Stem Cells in Parkinson’s Disease Newman, Mary B.; Bakay, Roy A.E. // Neurotherapeutics;Apr2008, Vol. 5 Issue 2, p237 

    Summary: The loss of dopaminergic neurons of the substantia nigra is the pathological hallmark characteristic of Parkinson’s disease (PD). The strategy of replacing these degenerating neurons with other cells that produce dopamine has been the main approach in the cell transplantation...

  • Miracle cures and embryonic science.  // Nature Biotechnology;Apr2001, Vol. 19 Issue 4, p287 

    Editorial. Focuses on the U.S. trial in which patients with a severe form of Parkinson's disease received human fetal nerve cell transplants. Side effects of trials; Need for evaluation of stem cell biology and its therapeutic potential before continuation of human testing of stem cells;...

  • Could Parkinson's be cured by therapeutic closing? Tanday, Sanjay // GP: General Practitioner;4/4/2008, p14 

    The article reports on the significance of therapeutic cloning as an effective treatment for Parkinson's disease as revealed by U.S. research. Researchers observed an improvement in the condition of mice with Parkinson's after dopamine cells were grafted onto their brains. The egg cells grew...

  • A New Cell Model for Parkinson's Disease.  // PLoS Biology;Nov2004, Vol. 2 Issue 11, p1686 

    The article presents a new cell model for Parkinson's disease. Despite the well-characterized cellular basis of Parkinson's disease, the molecular mechanisms responsible for dopamine neurodegeneration remain unknown. There is evidence that both genetic and environmental components are involved....

  • Now embryonic stem cells come without the risk of animal diseases. Nowak, Rachel // New Scientist;8/10/2002, Vol. 175 Issue 2355, p16 

    Reports the possibility of growing human embryonic stem cells free of animal diseases. Use of the stem cells to replace the dead nerve cells in patients with Parkinson's disease; Combination of the cells with cells from mouse fetuses and cow serum to grow them; Replacement of mouse cells and...

  • Journal of Clinical Investigation: Generating dopamine via cell therapy for Parkinson's disease.  // Biomedical Market Newsletter;7/19/2012, Vol. 21, p1 

    The article informs that replacement of dopaminergic neurons by neural transplantation with mouse embryonic stem cells is used in treatment of Parkinson's disease.

  • Cognitive deficits and striato-frontal dopamine release in Parkinsons disease. Nobukatsu Sawamoto; Paola Piccini; Gary Hotton; Nicola Pavese; Kris Thielemans; David J. Brooks // Brain: A Journal of Neurology;May2008, Vol. 131 Issue 5, p1294 

    Idiopathic Parkinsons disease (PD) is often accompanied by a pattern of executive deficits similar to those found in patients with frontal lobe lesions. We investigated whether such cognitive deficits are attributable to frontal lobe dysfunction as a direct consequence of impaired mesocortical...

  • The diabetes-Parkinson's connection. Altshul, Sara // Prevention;Nov2006, Vol. 58 Issue 11, p41 

    This article discusses a possible link between diabetes and Parkinson's disease. Finnish researchers found that healthy people who developed diabetes were twice as likely as non-diabetics to develop Parkinson's. According to study author Dr. Jaakko Ttuomilehto at the University of Helsinki,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics